Controlling blood loss is a crucial aspect of orthopedic surgery. Hemostatic agents can be used intraoperatively in combination with antifibrinolytics as part of an overall strategy to limit blood loss. Several new hemostatic agents have recently come to the market designed specifically for vascular surgery but have found uses in other surgical fields, including orthopedics. This article reviews the mechanisms of action and best uses of various mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants for achieving hemostasis in orthopedic surgery. Mechanical and active hemostats have been reported to successfully decrease blood loss from cancellous bone, capillaries, and venules. Flowable hemostats are generally favorable for use in small spaces where the swelling capabilities of mechanical and active hemostats can be detrimental to surrounding structures. Sealants are best used for closing defects in tissues.
AhnJMOhJS. Gelfoam embolization technique to prevent bone cement leakage during percutaneous vertebroplasty: comparative study of Gelfoam only vs. Gelfoam with venography. Korean J Neurotrauma. 2020;16(2):200–206. https://doi.org/10.13004/kjnt.2020.16.e42.
2.
AnfinsenOGSudmannBRaitMBangGSudmannE. Complications secondary to the use of standard bone wax in seven patients. J Foot Ankle Surg. 1993;32(5):505–508.
3.
BelayESO’DonnellJFlamantEHintonZKliftoCSAnakwenzeO. Intravenous tranexamic acid vs. Topical thrombin in total shoulder arthroplasty: a comparative study. J Shoulder Elbow Surg. 2021;30(2):312–316. https://doi.org/10.1016/j.jse.2020.05.039.
4.
BierbaumBECallaghanJJGalanteJORubashHEToomsREWelchRB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81(1):2–10. https://doi.org/10.2106/00004623-199901000-00002.
5.
CarabiniLMMorelandNCVealeyRJ, et al. A randomized controlled trial of low-dose tranexamic acid versus placebo to reduce red blood cell transfusion during complex multilevel spine fusion surgery. World Neurosurg. 2018;110:e572–e579. https://doi.org/10.1016/j.wneu.2017.11.070.
6.
ChapmanWCSinglaNGenykY, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg. 2007;205(2):256–265. https://doi.org/10.1016/j.jamcollsurg.2007.03.020.
HaaseDRTempletonKJRosenthalHGSweeneyKR. Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a retrospective review. J Am Acad Orthop Surg. 2020;28(6):248–255. https://doi.org/10.5435/JAAOS-D-18-00798.
9.
HarrisWHCrothersODMoyenBJBourneRB. Topical hemostatic agents for bone bleeding in humans. A quantitative comparison of gelatin paste, gelatin sponge plus bovine thrombin, and microfibrillar collagen. J Bone Joint Surg Am. 1978;60(4):454–456.
JiangTSongKYaoYPanPJiangQ. Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty. J Orthop Surg Res. 2019;14(1):235. https://doi.org/10.1186/s13018-019-1270-2.
13.
KusumaSKSheridanKCWasielewskiRC. Use of bovine thrombin to reduce blood loss in primary total knee arthroplasty. J Arthroplasty. 2013;28(8):1278–1281. https://doi.org/10.1016/j.arth.2012.12.015.
14.
LewisKMSpaziererDUrbanMDRedlHGoppeltA. Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents. Eursurg. 2013;45:213–220. https://doi.org/10.1007/s10353-013-0222-z.
15.
LiSChenBHuaZShaoYYinHWangJ. Comparative efficacy and safety of topical hemostatic agents in primary total knee arthroplasty: a network meta-analysis of randomized controlled trials. Medicine. 2021;100(12):e25087. https://doi.org/10.1097/MD.0000000000025087.
16.
MaLDaiLYangYLiuH. Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: a randomized controlled study. Medicine. 2018;97(49):e13511. https://doi.org/10.1097/MD.0000000000013511.
17.
MagyarCEAghalooTLAttiETetradisS. Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing. Neurosurgery. 2008;63(4 Suppl. 2):373–378. https://doi.org/10.1227/01.NEU.0000316859.03788.44.
18.
MenovskyTPlazierMRasschaertRMaasAIRParizelPMVerbekeS. Massive swelling of Surgicel® FibrillarTM hemostat after spinal surgery. Case report and a review of the literature. Minim Invasive Neurosurg. 2011;54(05/06):257–259. https://doi.org/10.1055/s-0031-1284394.
19.
MooIHChenJYQPagkaliwagaEHTanSWPoonKB. Bone wax is effective in reducing blood loss after total knee arthroplasty. J Arthroplasty. 2017;32(5):1483–1487. https://doi.org/10.1016/j.arth.2016.12.028.
20.
Morales SantiasMMas MartinezJMartínez Sanz-ReigJGimenezERománCVSuarez de PugaDB. Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study. Eur J Orthop Surg Traumatol. 2020;30(6):1003–1008. https://doi.org/10.1007/s00590-020-02656-9.
21.
MoťkováPBrožkováIVytřasováJKuklaR. Antimicrobial effect of OKCEL® H-D prepared from oxidized cellulose. Folia Microbiol. 2018;63(1):57–62. https://doi.org/10.1007/s12223-017-0534-7.
22.
ParkHJSukKSParkJW. A case of intraoperative anaphylaxis caused by bovine-derived thrombin. Allergy Asthma Immunol Res. 2018;10(2):184–186. https://doi.org/10.4168/aair.2018.10.2.184.
ScardinoMMartorelliFD’AmatoTFenocchioG, et al. Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. Int Orthop. 2019;43(12):2707–2714. https://doi.org/10.1007/s00264-019-04291-4.
25.
ScherKSCoilJA. Effects of oxidized cellulose and microfibrillar collagen on infection. Surgery. 1982;91(3):301–304.
26.
SchonauerCTessitoreEBarbagalloGAlbaneseVMoraciA. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13(S01):S89–S96. https://doi.org/10.1007/s00586-004-0727-z.
27.
ShinKHChoeJHJangKMHanSB. Use of bone wax reduces blood loss and transfusion rates after total knee arthroplasty. Knee. 2020;27(5):1411–1417. https://doi.org/10.1016/j.knee.2020.07.074.
28.
SinglaNKBallardJLMonetaGRandlemanCDJrRenkensKLAlexanderWA. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. J Am Coll Surg. 2009;209(1):68–74. https://doi.org/10.1016/j.jamcollsurg.2009.03.016.
29.
SizerSCCherianJJElmallahRDKPierceTPBeaverWBMontMA. Predicting blood loss in total knee and hip arthroplasty. Orthop Clin North Am. 2015;46(4):445–459. https://doi.org/10.1016/j.ocl.2015.06.002.
30.
SofuluOOzturkOPolatMBuyuktopcuOKesimerMDErolB. Efficacy and safety of tranexamic acid in resection and endoprosthetic reconstruction of distal femoral osteosarcomas in children: a retrospective cohort study. J Pediatr Orthop. 2021;41(8):e686–e691. https://doi.org/10.1097/BPO.0000000000001900.
WangHShanLZengHSunMHuaYCaiZ. Is fibrin sealant effective and safe in total knee arthroplasty? A meta-analysis of randomized trials. J Orthop Surg Res. 2014;9:36. https://doi.org/10.1186/1749-799X-9-36.
34.
WangMYArmstrongJKFisherTCMieselmanHJMcCombGJLevyML. A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis. Neurosurgery. 2001;49(4):962–968. https://doi.org/10.1097/00006123-200110000-00031.
35.
WangZXiaoLGuoHZhaoGMaJ. The efficiency and safety of fibrin sealant for reducing blood loss in primary total hip arthroplasty: a systematic review and meta-analysis. Int J Surg. 2017;37:50–57. https://doi.org/10.1016/j.ijsu.2016.12.007.
36.
WelliszTAnYHWenXKangQHillCMArmstrongJK. Infection rates and healing using bone wax and a soluble polymer material. Clin Orthop Relat Res. 2008;466(2):481–486. https://doi.org/10.1007/s11999-007-0067-5.
WongJAbrishamiAEl BeheiryH, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010;92(15):2503–2513. https://doi.org/10.2106/JBJS.I.01518.
39.
WuJJinYZhangJShaoHYangDChenJ. Hemostatic techniques following multilevel posterior lumbar spine surgery: a randomized control trial. J Spinal Disord Tech. 2014;27(8):442–446. https://doi.org/10.1097/BSD.0000000000000063.
40.
XuWLanZHuangY. Intraoperative injection of absorbable gelatin sponge (AGS) mixed with cement followed by spinal decompression to treat elderly with vertebral hemangiomas. BMC Musculoskelet Disord. 2020;21(1):125. https://doi.org/10.1186/s12891-020-3143-6.
41.
ZhangYLiuHHeFChenAYangHPiB. Does tranexamic acid improve bleeding, transfusion, and hemoglobin level in patients undergoing multilevel spine surgery? A systematic review and meta-analysis. World Neurosurg. 2019;127:289–301. https://doi.org/10.1016/j.wneu.2019.02.170.
42.
ZhouHGeJBaiYLiangCYangL. Translation of bone wax and its substitutes: history, clinical status and future directions. J Orthop Translat. 2019;17:64–72. https://doi.org/10.1016/j.jot.2019.03.005.
43.
ZirnaHKeatingSEDeVincentisAF. Topical hemostatic agents to reduce bleeding from cancellous bone surfaces: a comparison of Gelfoam paste and bone wax. J Foot Surg. 1987;26(6):496–500.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
